RITUXIMAB AND CYCLOPHOSPHAMIDE COMPARISON FOR EFFICACY AND SAFETY IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE

被引：4
|
作者：
Koneva, Olga [1 ]
Ananyeva, Lidia P. [1 ]
Garzanova, Liudmila [1 ]
Desinova, Oxana [1 ]
Ovsyannikova, Olga [1 ]
Starovoytova, Mayya [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.6816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0187
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [21] COMPARISON OF THE RITUXIMAB(RTM) IN MONOTHERAPY REGIMEN AND MYCOPHENOLATE MOFETIL (MMF) EFFICACY AND SAFETY IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 704 - 704
  • [22] THE STUDY OF THE NINTEDANIB SAFETY PROFILE IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga A.
    Garzanova, Liudmila
    Ananyeva, Lidia
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    CHEST, 2023, 164 (04) : 5483A - 5484A
  • [23] THE PARAMETERS RELATED TO DECLINE OF LUNG FUNCTION ON RITUXIMAB THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Ananyeva, L. P.
    Garzanova, L.
    Glukhova, S.
    Desinova, O.
    Koneva, O.
    Starovoytova, M.
    Shayakhmetova, R.
    Ovsyannikova, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 727 - 727
  • [24] EFFICIENCY OF RITUXIMAB THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS DEPENDING ON THE FORM AND DURATION OF THE DISEASE
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga A.
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    CHEST, 2023, 164 (04) : 3118A - 3119A
  • [25] Efficacy of Mycophenolate As a Maintenance Therapy Following the Administration of Cyclophosphamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
    Narvaez, Javier
    Borrell Panos, Helena
    Castellvi, Ivan
    Heredia, Sergi
    Millan, Milena
    Herrera, Susana
    Armengol, Eulalia
    Maria LLobet, Josep
    Miquel Nolla, Joan
    Molina, Maria
    Jose Alegre, Juan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [27] Efficacy of Cyclophospamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
    Espinosa, Gerard
    Pilar Simeon, Carmen
    Plasin, Miguel Angel
    Xaubet, Antoni
    Munoz, Xavier
    Fonollosa, Vicent
    Cervera, Ricard
    Vilardell, Miguel
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (05): : 239 - 245
  • [28] Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients
    Morgan, Kelly
    Woollard, Charlotte
    Beinart, Dylan
    Host, Lauren, V
    Roddy, Janet
    INTERNAL MEDICINE JOURNAL, 2023, 53 (07) : 1147 - 1153
  • [29] RITUXIMAB EXPERIENCE IN PATIENTS WITH LONGSTANDING SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A SERIES OF 14 PATIENTS
    Sari, A.
    Guven, D.
    Armagan, B.
    Kilic, L.
    Erden, A.
    Akdogan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1262 - 1263
  • [30] THE EFFECT OF CYCLOPHOSPHAMIDE ON LUNG FUNCTION IN DIFFERENT STAGES OF INTERSTITIAL LUNG DISEASE ASSOCIATED TO SYSTEMIC SCLEROSIS
    Van Den Hombergh, W. M. T.
    Teesselink, E.
    Knaapen-Hans, H. K. A.
    Simons, S. O.
    van den Hoogen, F. H. J.
    Fransen, J.
    Vonk, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 526 - 526
12345